Market Research Report
Global Hospital Acquired Infections (HAI) Market - 2019-2026
|Published by||DataM Intelligence||Product code||757913|
Delivery time: 1-2 business days
|Global Hospital Acquired Infections (HAI) Market - 2019-2026|
|Published: October 1, 2019||Content info:||
The Hospital Acquired Infections (HAI) market is estimated to reach a market value of USD XX million by 2025 with the market growing at a CAGR of XX% in the forecasted period 2019-2026. Hospital-acquired infections (HAI), or nosocomial infections, are acquired in a hospital or other health care facilities.
Most common factors causing the growth of the hospital acquired infection market is the growing elderly population globally as the elderly population is more prone to infections due to their low physical immunity. Moreover, the low level of hygiene in hospitals, poor infrastructure management, and poor sterilizing techniques used at healthcare institutions are consequently increasing the number of hospital acquired infection cases.
National 2015 Standardized Infection Ratios (SIRs) Calculated
HAI Type Hospitals Predicted Infection
Catheter-associated Urinary Tract Infection (CAUTI) 4,165 27,029
Central Line-associated Bloodstream Infection (CLABSI) 3,935 27,313
Surgical Site Infection (SSI)- Abdominal Hysterectomy 3,248 2,091
MRSA Bacteremia LabID Event 4,035 8,898
Surgical Site Infection (SSI) - Colon Surgery 3,395 9,280
Increasing incidences of different types of hospital acquired infection, advancement in technologies implemented in devices that control infection are some of the growth factors boosting the HAI market. However, lack of awareness towards hospital acquired infections, and increasing use of outpatient treatment are hindering the growth of the market.
The global hospital acquired infection market is segmented by infection type into Urinary Tract Infections, Ventilator Associated Pneumonia, Bloodstream Infections, Surgical Site Infections, and Others. Among these, the Urinary Tract Infections hold the largest market share in 2017 with increasing patients undergoing urological manipulations, long-stay elderly male patients and patients with debilitating diseases. The urinary tract infections segment is also growing at the highest CAGR during the forecast period.
Further, based on treatment, the Hospital Acquired Infections (HAI) market is segmented into antibacterial, antiviral, antifungal, and other treatments. Among these, the antibacterial treatment segment accounted for the largest market share in 2017, due to their increased efficiency in hospital acquired infections.
The below graph shows the estimated number of healthcare-associated infections (HAIs) in U.S. acute care hospitals in 2011. Based on a survey, it was estimated that around 722 thousand HAIs occurred in U.S hospitals in 2011.
Total No. of Study: 262
Geographically, the Hospital Acquired Infections (HAI) market is segmented into North America, Europe, Asia-Pacific, South America, and RoW. North America is dominating the global HAI market due to growing development of new therapeutic procedures in bacterial infections.
The global Hospital Acquired Infections (HAI) market is a highly consolidated with few companies accounting for majority of the market share. Companies are highly investing in R & D and are collaborating with other companies for developing products.
Some of the major companies in global Hospital Acquired Infections (HAI)market include 3M, Advanced Sterilization Products, Becton Dickinson and company, STERIS Corp., Getinge AB, Cantel Medical Corp., Belimed AG, Abbott Laboratories, Pfizer Inc., and Bayer AG.
Key Market Segments
1 Methodology and Scope